Aeon Global Health Corp. (AGHC) Financial Statements (2024 and earlier)
Company Profile
Business Address |
2225 CENTENNIAL DRIVE GAINESVILLE, 30504 |
State of Incorp. | DE |
Fiscal Year End | June 30 |
Industry (SIC) | 8071 - Medical Laboratories (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
6/30/2019 Q4 | 3/31/2019 Q3 | 12/31/2018 Q2 | 9/30/2018 Q1 | 6/30/2018 Q4 | 3/31/2018 Q3 | 12/31/2017 Q2 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 521 | 323 | 570 | 723 | 470 | 357 | |||
Cash and cash equivalents | 521 | 323 | 570 | 723 | 470 | 357 | |||
Receivables | 2,601 | 2,492 | 2,701 | 2,507 | 2,666 | 2,468 | |||
Inventory, net of allowances, customer advances and progress billings | 489 | 429 | 408 | 453 | 396 | 398 | |||
Inventory | 489 | 429 | 408 | 453 | 396 | 398 | |||
Other undisclosed current assets | 110 | 108 | 79 | 54 | 93 | 39 | |||
Total current assets: | 3,721 | 3,352 | 3,758 | 3,738 | 3,625 | 3,261 | |||
Noncurrent Assets | |||||||||
Property, plant and equipment | 1,060 | 1,174 | 1,293 | 1,421 | 1,575 | 1,780 | |||
Deposits noncurrent assets | 10 | 10 | |||||||
Deferred tax assets, net | ✕ | ✕ | 5,816 | 7,357 | 7,357 | ||||
Other undisclosed noncurrent assets | 5,816 | 5,816 | 5,816 | ||||||
Total noncurrent assets: | 6,876 | 6,990 | 7,109 | 7,237 | 8,943 | 9,148 | |||
TOTAL ASSETS: | 10,598 | 10,342 | 10,867 | 10,975 | 12,568 | 12,409 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 5,224 | 4,324 | 4,427 | 5,175 | 4,407 | 4,579 | |||
Interest and dividends payable | 495 | 371 | 237 | 985 | 902 | 816 | |||
Taxes payable | 516 | 516 | 516 | 516 | |||||
Accounts payable | 2,028 | 1,608 | 1,644 | 1,437 | 1,361 | 1,269 | |||
Accrued liabilities | 2,185 | 1,829 | 2,030 | 2,238 | 2,144 | 2,493 | |||
Debt | 3,050 | 3,172 | 2,545 | ||||||
Deferred rent credit | 224 | 214 | 204 | 195 | 185 | ✕ | |||
Derivative instruments and hedges, liabilities | 386 | 223 | 441 | 1,324 | 1,471 | 185 | |||
Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 170 | ||
Due to related parties | 1,698 | ||||||||
Other undisclosed current liabilities | 249 | 447 | 459 | 608 | 603 | 855 | |||
Total current liabilities: | 7,781 | 5,208 | 5,531 | 10,352 | 9,837 | 8,335 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 3,114 | ||||||||
Long-term debt, excluding current maturities | 3,114 | ||||||||
Liabilities, other than long-term debt | 1,622 | 3,575 | 718 | 135 | 113 | 90 | |||
Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 90 | ||
Deferred rent credit | 207 | 183 | 157 | 135 | 113 | ✕ | |||
Due to related parties | 1,415 | 3,114 | |||||||
Derivative instruments and hedges, liabilities | 279 | 560 | |||||||
Total noncurrent liabilities: | 1,622 | 3,575 | 3,831 | 135 | 113 | 90 | |||
Total liabilities: | 9,403 | 8,783 | 9,363 | 10,487 | 9,950 | 8,425 | |||
Equity | |||||||||
Equity, attributable to parent, including: | 1,195 | 1,559 | 1,505 | 489 | 2,618 | 3,984 | |||
Preferred stock | 63 | 63 | 63 | 63 | 63 | 63 | |||
Common stock | 10 | 26 | 26 | 26 | 26 | 21 | |||
Additional paid in capital | 47,674 | 46,915 | 46,600 | 45,089 | 44,958 | 44,530 | |||
Accumulated deficit | (46,552) | (45,445) | (45,184) | (44,689) | (4,229) | (40,630) | |||
Other undisclosed equity, attributable to parent | (38,200) | ||||||||
Other undisclosed equity | (0) | ||||||||
Total equity: | 1,195 | 1,559 | 1,505 | 489 | 2,618 | 3,984 | |||
TOTAL LIABILITIES AND EQUITY: | 10,598 | 10,342 | 10,867 | 10,975 | 12,568 | 12,409 |
Income Statement (P&L) ($ in thousands)Annual | Quarterly
6/30/2019 Q4 | 3/31/2019 Q3 | 12/31/2018 Q2 | 9/30/2018 Q1 | 6/30/2018 Q4 | 3/31/2018 Q3 | 12/31/2017 Q2 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 2,587 | 3,545 | 3,741 | 3,356 | 4,056 | 5,531 | ||
Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 5,531 | |
Cost of revenue | (1,141) | (1,204) | (1,457) | (827) | (958) | (889) | ||
Gross profit: | 1,446 | 2,341 | 2,285 | 2,529 | 3,097 | 4,643 | ||
Operating expenses | (2,639) | (2,303) | (2,443) | (3,427) | (3,244) | |||
Other undisclosed operating income (loss) | (1,828) | (315) | (69) | (782) | (21) | |||
Operating income (loss): | (382) | (613) | (88) | (695) | (329) | 1,378 | ||
Nonoperating income (expense) | 96 | 490 | (312) | 118 | (1,380) | 131 | ||
Investment income, nonoperating | 116 | 499 | (135) | 147 | (1,286) | 293 | ||
Other nonoperating income (expense) | 27 | (9) | (129) | 2 | (50) | (124) | ||
Interest and debt expense | (47) | (47) | (49) | 64 | (37) | (32) | ||
Other undisclosed income from continuing operations before equity method investments, income taxes | ||||||||
Income (loss) from continuing operations before equity method investments, income taxes: | (333) | (170) | (449) | (513) | (1,746) | 1,477 | ||
Other undisclosed income (loss) from continuing operations before income taxes | 47 | 0 | 49 | (64) | 37 | 32 | ||
Income (loss) from continuing operations before income taxes: | (286) | (169) | (400) | (577) | (1,709) | 1,509 | ||
Income tax expense (benefit) | 15 | (6) | (9) | (1,601) | (3) | (4,493) | ||
Other undisclosed loss from continuing operations | ||||||||
Loss from continuing operations: | (271) | (175) | (409) | (2,177) | (1,713) | (2,984) | ||
Loss before gain (loss) on sale of properties: | (271) | (175) | (409) | (2,177) | (1,713) | (2,984) | ||
Net loss: | (271) | (175) | (409) | (2,177) | (1,713) | (2,984) | ||
Other undisclosed net income (loss) attributable to parent | (26) | 26 | ||||||
Net loss attributable to parent: | (271) | (175) | (409) | (2,204) | (1,686) | (2,984) | ||
Preferred stock dividends and other adjustments | (86) | (86) | (86) | (83) | (86) | (86) | ||
Other undisclosed net loss available to common stockholders, basic | (1) | |||||||
Net loss available to common stockholders, diluted: | (357) | (261) | (495) | (2,288) | (1,772) | (3,070) |
Comprehensive Income ($ in thousands)Annual | Quarterly
6/30/2019 Q4 | 3/31/2019 Q3 | 12/31/2018 Q2 | 9/30/2018 Q1 | 6/30/2018 Q4 | 3/31/2018 Q3 | 12/31/2017 Q2 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (271) | (175) | (409) | (2,177) | (1,713) | (2,984) | ||
Comprehensive loss, net of tax, attributable to parent: | (271) | (175) | (409) | (2,177) | (1,713) | (2,984) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.